Biomarker and testing questions

Ask whether CD20 expression and pathology review support the treatment.

Second-opinion questions

Does the pathology report confirm the marker and disease subtype that make this treatment appropriate?

Safety discussion reminder

Infusion reactions and infection risks should be reviewed with the treating team.

Official source links